Backed by the British government’s £452 million Battery Innovation Program, clean-tech firm Altilium is spearheading a ...
Transaction Gives CuriosityStream Control of Its Top Non-English-Speaking Market, Creating New Opportunities for ...
Phased review by EMA aims to accelerate assessment of company's investigational drug daraxonrasib in pancreatic cancer based on unprecedented clinical results from pivotal Phase 3 RASolute 302 trial R ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results